Cargando…
Maximizing biomarker discovery by minimizing gene signatures
BACKGROUND: The use of gene signatures can potentially be of considerable value in the field of clinical diagnosis. However, gene signatures defined with different methods can be quite various even when applied the same disease and the same endpoint. Previous studies have shown that the correct sele...
Autores principales: | Chang, Chang, Wang, Junwei, Zhao, Chen, Fostel, Jennifer, Tong, Weida, Bushel, Pierre R, Deng, Youping, Pusztai, Lajos, Symmans, W Fraser, Shi, Tieliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287502/ https://www.ncbi.nlm.nih.gov/pubmed/22369133 http://dx.doi.org/10.1186/1471-2164-12-S5-S6 |
Ejemplares similares
-
Maximum predictive power of the microarray-based models for clinical outcomes is limited by correlation between endpoint and gene expression profile
por: Zhao, Chen, et al.
Publicado: (2011) -
The Bimodality Index: A Criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data
por: Wang, Jing, et al.
Publicado: (2009) -
Editorial: Integrative Toxicogenomics: Analytical Strategies to Amalgamate Exposure Effects With Genomic Sciences
por: Bushel, Pierre R., et al.
Publicado: (2018) -
Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems
por: Hess, Kenneth R, et al.
Publicado: (2011) -
Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments
por: Qi, Yuan, et al.
Publicado: (2015)